PCK2

phosphoenolpyruvate carboxykinase 2, mitochondrial

Basic information

Region (hg38): 14:24094053-24110598

Links

ENSG00000100889NCBI:5106OMIM:614095HGNC:8725Uniprot:Q16822AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • phosphoenolpyruvate carboxykinase deficiency, mitochondrial (Limited), mode of inheritance: AR
  • phosphoenolpyruvate carboxykinase deficiency (Supportive), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PCK2 gene.

  • Phosphoenolpyruvate carboxykinase deficiency, mitochondrial (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCK2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
26
clinvar
7
clinvar
35
missense
110
clinvar
10
clinvar
5
clinvar
125
nonsense
5
clinvar
5
start loss
0
frameshift
6
clinvar
6
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
1
clinvar
6
splice region
4
2
1
7
non coding
11
clinvar
2
clinvar
13
Total 1 0 127 48 14

Highest pathogenic variant AF is 0.000171

Variants in PCK2

This is a list of pathogenic ClinVar variants found in the PCK2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-24094411-C-T Benign (Jan 29, 2024)559129
14-24094416-T-G Uncertain significance (May 11, 2023)2165082
14-24094417-G-C not specified Uncertain significance (Mar 30, 2024)2721282
14-24094422-G-A not specified Uncertain significance (Jul 12, 2023)2611645
14-24094423-C-A Likely benign (Jan 07, 2024)3020349
14-24094439-G-A Retinitis pigmentosa 27 Uncertain significance (Mar 29, 2024)3065586
14-24096872-T-C Likely benign (Feb 13, 2023)2894000
14-24096879-G-A Likely benign (Nov 21, 2023)2995460
14-24096930-C-G not specified • Phosphoenolpyruvate carboxykinase deficiency, mitochondrial Conflicting classifications of pathogenicity (Jan 09, 2024)374449
14-24096935-C-T not specified Uncertain significance (Dec 15, 2023)3210243
14-24096936-G-A Uncertain significance (Dec 11, 2023)1368796
14-24096954-G-A not specified Uncertain significance (Dec 11, 2023)2068310
14-24096956-G-A not specified Uncertain significance (Oct 05, 2022)2396840
14-24096983-C-T Uncertain significance (Dec 05, 2022)2731744
14-24097012-C-T Conflicting classifications of pathogenicity (Jan 08, 2024)1634621
14-24097019-C-A Uncertain significance (Jan 14, 2023)1524621
14-24097019-C-T Phosphoenolpyruvate carboxykinase deficiency, mitochondrial • not specified Uncertain significance (Dec 15, 2022)1032912
14-24097024-G-T Likely benign (Nov 27, 2023)2699332
14-24097041-T-C Uncertain significance (Jun 06, 2023)3016853
14-24097049-T-G not specified Uncertain significance (Dec 01, 2022)2330800
14-24097052-G-A PCK2-related disorder Benign (Jan 16, 2024)559130
14-24097059-C-G not specified Uncertain significance (Nov 22, 2022)2052577
14-24097080-C-T not specified Likely benign (Sep 09, 2021)2248937
14-24097093-G-A Uncertain significance (Feb 17, 2022)1931087
14-24097112-C-T Uncertain significance (Feb 18, 2023)2718337

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PCK2protein_codingprotein_codingENST00000216780 1016546
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.75e-230.000368124495212511257480.00499
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2034184071.030.00002514144
Missense in Polyphen204197.531.03282008
Synonymous0.6931391500.9280.000008591331
Loss of Function-0.2443432.51.050.00000213280

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.008960.00894
Ashkenazi Jewish0.000.00
East Asian0.0008700.000870
Finnish0.0002350.000231
European (Non-Finnish)0.007820.00777
Middle Eastern0.0008700.000870
South Asian0.001930.00190
Other0.005720.00572

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. {ECO:0000250}.;
Disease
DISEASE: Mitochondrial phosphoenolpyruvate carboxykinase deficiency (M-PEPCKD) [MIM:261650]: Metabolic disorder resulting from impaired gluconeogenesis. It is a rare disease with less than 10 cases reported in the literature. Clinical characteristics include hypotonia, hepatomegaly, failure to thrive, lactic acidosis and hypoglycemia. Autopsy reveals fatty infiltration of both the liver and kidneys. The disorder is transmitted as an autosomal recessive trait. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Citrate cycle (TCA cycle) - Homo sapiens (human);Pyruvate metabolism - Homo sapiens (human);Adipocytokine signaling pathway - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Insulin resistance - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);Proximal tubule bicarbonate reclamation - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Adipogenesis;Transcription factor regulation in adipogenesis;PPAR signaling pathway;PI3K-Akt Signaling Pathway;DNA Damage Response (only ATM dependent);Metabolism of carbohydrates;Citrate cycle;Glycolysis and Gluconeogenesis;Metabolism;TCA cycle;Glucocorticoid receptor regulatory network;gluconeogenesis;Gluconeogenesis;Glucose metabolism (Consensus)

Recessive Scores

pRec
0.818

Intolerance Scores

loftool
0.999
rvis_EVS
0.27
rvis_percentile_EVS
70.75

Haploinsufficiency Scores

pHI
0.211
hipred
N
hipred_score
0.213
ghis
0.432

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pck2
Phenotype

Gene ontology

Biological process
pyruvate metabolic process;gluconeogenesis;propionate catabolic process;cellular response to insulin stimulus;response to lipid;response to starvation;glycerol biosynthetic process from pyruvate;hepatocyte differentiation;cellular response to glucose stimulus;cellular response to dexamethasone stimulus
Cellular component
mitochondrion;mitochondrial matrix;cytosol
Molecular function
phosphoenolpyruvate carboxykinase activity;phosphoenolpyruvate carboxykinase (GTP) activity;protein binding;GTP binding;manganese ion binding